Navigation Links
Burnham researchers illuminate mechanisms that regulate DNA damage control and replication
Date:1/5/2009

LA JOLLA, Calif., January 5, 2008Scientists at Burnham Institute for Medical Research (Burnham) have demonstrated important new roles for the protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring damage control during DNA replication and reinitiating replication following DNA repair. Since Ddk is often deregulated in human cancers, this new understanding of its role in DNA damage control could help shape new cancer therapies. The research was published in the December 24 issue of Molecular Cell.

Accurate DNA replication is essential for maintaining the stability of the genome. When errors occur, replication halts through a quality control process called the S-phase checkpoint. Replication is only restarted after the errors have been repaired. One of several proteins required for DNA replication, Ddk has long been thought to play an important role in the S-phase checkpoint, despite the lack of definitive evidence. In this study, Burnham researchers show that Ddk actively controls S-phase checkpoint signaling and plays a crucial role in triggering the re-initiation of DNA replication once damage has been repaired.

"This protein kinase complex is not only monitoring DNA replication, it's also monitoring the S-phase checkpoint," says Wei Jiang, Ph.D., the study's principal investigator. "If replication is accurate, then Ddk allows DNA synthesis to continue normally. If there is DNA damage, replication is halted at this checkpoint. The most important thing is to stop replication in order to allow for DNA repair and to avoid catastrophe for the cell. Our study demonstrates that Ddk not only activates the initiation of DNA replication, but it also monitors the checkpoint during DNA damage control and eventually overrides the checkpoint to re-initiates DNA replication."

These findings suggest a highly complex role for Ddk in DNA replication, S-phase checkpoint monitoring and DNA replication re-initiation after repair. The r
'/>"/>

Contact: Josh Baxt
jbaxt@burnham.org
858-795-5236
Burnham Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Burnham and HeadNorth Foundation join forces to advance spinal cord research
2. Recent developments at Burnham Institute
3. Recent developments at the Burnham Institute
4. Relocation plan of metastatic cancer cells uncovered by Stanford researchers
5. Researchers at Columbia University Medical Center link blood sugar to normal cognitive aging
6. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
7. Nutritious fast-food kids meals are scarce, researchers find
8. UIC researchers hunting drugs for devastating parasitic disease
9. Indiana University researchers revisit male bisexuality
10. Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say
11. Mayo researchers find potential links between breast density and breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewsw... professional cycling team dedicated to ethical sp...ng champions, announced today that it will become ...itions Optical as a new sponsor of the team. Trans... of adaptive eyewear, offering the most advanced p...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
..., SAN DIEGO, Jan. 6 NuVasive, Inc. (Nasdaq: NU...ng products for minimally disruptive surgical trea...kianov, Chairman and Chief Executive Officer, is s...2009, at 11:00 a.m. PT. , , A live Web cast of th...
..., SAN DIEGO, Jan. 6 Orexigen(R) Therapeutics,...ny focused on the treatment of,obesity, today anno...h Annual,J.P. Morgan Healthcare Conference. The de... California, Webcast link: , http://metameetin...
..., Frontier Service Design Creates Tangible Value b... Jan. 6 Frontier Service Design, LLC, a firm that...s that create new and recurring revenue streams fo... around business opportunities that yield new sour...
..., Completed Phase 2 Bladder Augment Trial and Plan...kthrough in Kidney Regeneration Program: Preclini...ON, Pa., Jan. 6 Tengion Inc., a clinical-stage or...ef executive officer, is scheduled to present at t...
..., MILAN, Italy, Jan. 6 A pancreatic cancer pa...reated using a new, faster form of,radiotherapy th... while,extending more advanced care to more patien.... , "We see three major benefits with RapidArc...
..., Rock & Roll Hall of Fame inductees Jackson B...ing attention to the nation,s biggest problem: the...nt Emissary, a DC-based event planning company, an...ll Blue Diamond Ball will be held January 20, 2009...
Other Medicine News:Health News:NuVasive to Present at 27th Annual J.P. Morgan Healthcare Conference 2Health News:First Service Design Firm Launches in United States 2Health News:Tengion to Present at 27th Annual JP Morgan Healthcare Conference 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 2Health News:First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center 3Health News:Health for All Blue Diamond Ball Scheduled to Celebrate Obama's Inauguration 2
(Date:11/25/2009)...a, Nov. 25 /PRNewswire-Asia-FirstCall/ -- China Sk...he Company") (Nasdaq: CSKI ), a,leading fully int...ucing,over-the-counter drugs in the People,s Repub...pany recently passed the Chinese National Institut... Products ("ICPBP") examination,for two of its new...
(Date:11/25/2009)... Nov. 25 According to Millennium R...al technology market intelligence, the nearly $3 b...continue to see rapid growth over the next five ye...S Markets for Trauma Devices 2010 report finds ...he next five years, with competitors introducing s...
(Date:11/25/2009)...herlands and JOHANNESBURG, November 25 /PRNewswire... Pyxis Discovery announced today,that they have si...oth,companies, services. , Pyxis,s world ...xpertise,will be coupled with iThemba,s service di...y support to projects identified through Pyxis,in...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Home For the Holidays 3A MyShrink com Announces the Second in its Successful Six Part Webinar Series 3A 26quot 3BAbandonment 3A The Hidden Fear 26quo 62006 1Home For the Holidays 3A MyShrink com Announces the Second in its Successful Six Part Webinar Series 3A 26quot 3BAbandonment 3A The Hidden Fear 26quo 62006 2Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 1Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 2Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 3Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 62004 4NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Deal 62002 1NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Deal 62002 2
..., April 17 Schering-Plough,Corporation (NYSE: SG...nt of,chronic hepatitis C virus (HCV) infection, a...dy as well as from several other clinical studies,...ETOL(R) (ribavirin, USP),combination therapy will ...tudy of the Liver (EASL) 43rd annual meeting in Mi...
... April 16 Kosan Biosciences,Incorporated (Nasdaq:...tary,nuclear export inhibitors (NEI) showing poten...ility in leukemia xenograft models, and further,el...orrelating inhibition,of the target CRM1 with indu...pared to normal cells. Data on Kosan,s NEIs were p...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 2Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 3Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR 4
New Image Lock 'n Roll Drainable Pouch, Transparent with Filter
New Image Drainable Pouch,
New Image Drainable Pouch with Filter,
New Image Drainable Mini-Pouch, Beige with Lock 'n Roll
Medicine Products: